Graviti Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Graviti Pharmaceuticals Private Limited

Graviti Pharmaceuticals Private Limited, a active private limited company, was established on 27 December 2012 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2012PTC085058. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹49.00 Cr.

Formerly known as Abhayam Pharmaceuticals Private Limited. It upholds a compliant status. Employing 841 professional, Its leadership includes Jaganmohan Rao Boinapalli (Director), Suguna Raman (Director), Dheeraj Kumar Gorukanti (Managing Director). Past directors included Jaganmohan Rao Boinapalli, Ravender Gorukanti Rao, Dheeraj Kumar Gorukanti. It holds ₹327.00 Cr open charges and ₹405.25 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at House No. 8-2-248/1/7/64, Plot No.64, Nagarjuna Co-Operative Housing Society,, Punjagutta, Hyderabad, Telangana, 500082.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TG2012PTC085058

  • Registration Number

    085058

  • Incorporation Date

    27 December 2012

  • Authorized Capital

    ₹50.00 Cr

  • Paid-Up Capital

    ₹49.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 50.00 Cr
  • Paid Up Capital ₹ 49.00 Cr
  • Company Age 13 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 327.00 Cr
  • Satisfied Charges ₹ 405.25 Cr
  • Revenue Growth **** 70.69%
  • Profit Growth **** 9986.77%
  • Ebitda **** 151.86%
  • Net Worth 42.85%
  • Total Assets **** 15.17%
Company report

Graviti Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Graviti Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Graviti Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Jaganmohan Rao Boinapalli Director 24 Mar 2025 Current
Suguna Raman Director 27 Dec 2012 Current
Dheeraj Kumar Gorukanti Managing Director 27 Dec 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2025 Past
Pramod Abcsdd Director 13 Mar 2017 Past
Pramod Abcsdd Director 31 Aug 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Graviti Pharmaceuticals.

Graviti Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 70.69% increase. The company also saw a substantial improvement in profitability, with a 9986.77% increase in profit. The company's net worth Soared by an impressive increase of 42.85%.

Graviti Pharmaceuticals revenue growth over time
Graviti Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 70.69%
*******
*******
*******
*******
Revenue from Operations
*******
 73.77%
*******
*******
*******
*******
Total Assets
*******
 15.17%
*******
*******
*******
*******
Profit or Loss
*******
 9986.77%
*******
*******
*******
*******
Net Worth
*******
 42.85%
*******
*******
*******
*******
EBITDA
*******
 151.86%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Graviti Pharmaceuticals?

In 2024, Graviti Pharmaceuticals had a promoter holding of 100.00%. The company had 3 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,270,000,000.00

Satisfied Charges

₹4,052,500,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 179.00 Cr
  • Others : 148.00 Cr
Latest Charge Details
Date Lender Amount Status
15 Oct 2024 Hdfc Bank Limited ₹179.00 Cr Open
26 Sep 2023 Others ₹148.00 Cr Open
22 Sep 2017 Axis Bank Limited ₹245.25 Cr Satisfied
31 Mar 2015 Axis Bank Limited ₹160.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Graviti Pharmaceuticals?

Graviti Pharmaceuticals has a workforce of 841 employees as of Sep 01, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Graviti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Graviti Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Graviti Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Graviti Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    A charge with Others of Rs. 148.00 Cr registered on 26 Sep 2023 with Charge ID 100793871 was modified on 18 Aug 2025. was recorded as a recent event.

  • Balance Sheet

    The activity Graviti Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    Progress on Jaganmohan Rao Boinapalli was appointed as a Director was appointed as a Director on 24 Mar 2025 & has been associated with this company since 10 months 23 days . was documented.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 179.00 Cr registered on 15 Oct 2024 with Charge ID 100998039 was modified on 21 Jan 2025. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 22 Sep 2017 via Charge ID 100132716 with Axis Bank Limited was fully satisfied on 12 Nov 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Graviti Pharmaceuticals Private Limited?

The CIN of Graviti Pharmaceuticals Private Limited is U24232TG2012PTC085058.

Where is Graviti Pharmaceuticals Private Limited headquartered?

Graviti Pharmaceuticals Private Limited is headquartered at House No. 8-2-248/1/7/64, Plot No.64, Nagarjuna Co-Operative Housing Society,, Punjagutta, Hyderabad, Telangana, 500082.

When was Graviti Pharmaceuticals Private Limited incorporated?

Graviti Pharmaceuticals Private Limited was incorporated on 27 December 2012.

Who are the current directors of Graviti Pharmaceuticals Private Limited?

The current directors of Graviti Pharmaceuticals Private Limited are

What is the primary industry of Graviti Pharmaceuticals Private Limited?

The primary industry of Graviti Pharmaceuticals Private Limited is Manufacturing.

Is Graviti Pharmaceuticals Private Limited a listed company?

Graviti Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Graviti Pharmaceuticals Private Limited?

The authorized capital of Graviti Pharmaceuticals Private Limited is ₹50.00 Cr, and the paid-up capital is ₹49.00 Cr.

What is the compliance status of Graviti Pharmaceuticals Private Limited?

The compliance status of Graviti Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available